AstraZeneca

AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med
Fierce Pharma
Fri, 10/14/22 - 10:21 am
South Korea
Alvogen
AstraZeneca
Zoladex
AstraZeneca’s Covid-19 nasal-spray version fails in trial
Clinical Trials Arena
Tue, 10/11/22 - 10:45 am
AstraZeneca
COVID-19
vaccines
clinical trials
intranasal vaccines
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Roche
FDA
diagnostics
Medtech
HER2-low breast cancer
Enhertu
AstraZeneca
Daiichi Sankyo
AstraZeneca's Evusheld loses potency against new omicron subvariant, FDA warns
Fierce Pharma
Wed, 10/5/22 - 10:37 am
AstraZeneca
COVID-19
Omicron BA.4.6
Evusheld
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
Wed, 10/5/22 - 10:35 am
pharma marketing
DTC advertising
AstraZeneca
eosinophilic asthma
asthma
Fasenra
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
AstraZeneca
M&A
Alexion
LogicBio Therapeutics
genomic medicine
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
FDA
GSK
Amicus Therapeutics
AstraZeneca
Novartis
Supernus
JNJ
Ipsen
Y-mAbs Therapeutics
PCSK9 pipeline shows signs of saturation
EP Vantage
Tue, 09/27/22 - 10:21 am
AstraZeneca
ION449
Ionis Pharmaceuticals
Novartis
Leqvio
PCSK9 inhibitors
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
AstraZeneca, Merck withdraw Lynparza's late-line ovarian cancer nod amid PARP inhibitor death concerns
Fierce Pharma
Sun, 09/25/22 - 02:28 pm
AstraZeneca
Merck
Lynparza
ovarian cancer
AstraZeneca dumps Ionis drug despite hit in phase 2 cholesterol trial
Fierce Biotech
Fri, 09/23/22 - 11:00 am
AstraZeneca
Ionis Pharmaceuticals
clinical trials
ION449
cholesterol
AstraZeneca's Alexion bet continues to pay off as danicopan improves hemoglobin levels in phase 3
Fierce Biotech
Mon, 09/19/22 - 09:25 am
AstraZeneca
Alexion
danicopan
paroxysmal nocturnal hemoglobinuria
Sanofi, AstraZeneca win EMA support for RSV drug in babies
BioPharma Dive
Sun, 09/18/22 - 10:22 pm
AstraZeneca
Beyfortus
RSV
Europe
pediatric
infants
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Morningstar
Wed, 09/14/22 - 09:31 am
Roche
AstraZeneca
Eli Lilly
R&D
drug pricing
AstraZeneca wins federal class-action suit, judge dismisses shareholders' misleading claims
Endpoints
Tue, 09/13/22 - 07:57 pm
AstraZeneca
legal
shareholders
vaccines
COVID-19
Data drip sheds little light on how Ionis, AstraZeneca compare to Alnylam in rare disease
Fierce Biotech
Wed, 09/7/22 - 10:18 am
AstraZeneca
Ionis Pharmaceuticals
Alnylam
antisense
ATTRv-PN
aplontersen
AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer
NASDAQ
Tue, 09/6/22 - 05:04 pm
AstraZeneca
Imfinzi
biliary tract cancer
FDA
AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK
Fierce Pharma
Wed, 08/31/22 - 10:39 pm
AstraZeneca
GSK
Chris Sheldon
executives

Pages